LKB1 catalytic activity contributes to estrogen receptor α signaling

Molecular Biology of the Cell

Volumn 20, Issue 11, 2009, Pages 2785-2795

  Nath Sain, Suchita ^a   Marignani, Paola A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROTEIN KINASE LKB1; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CATALYSIS; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TRANSACTIVATION;

BLOTTING, WESTERN; CATALYSIS; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MICROSCOPY, FLUORESCENCE; MUTATION; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 66349089845     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-11-1138     Document Type: Article

References (67)

1. Augereau, P., Miralles, F., Cavailles, V., Gaudelet, C., Parker, M., and Rochefort, H. (1994). Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol. Endocrinol. 8, 693-703.
2. Avizienyte, E., et al. (1999). LKB1 somatic mutations in sporadic tumors. Am. J. Pathol. 154, 677-681.
3. Barnes, D., and Gillett, C. (1998). Cyclin D1 in breast cancer. Breast Cancer Res. Treat. 52, 1-15.
4. Batsche, E., Desroches, J., Bilodeau, S., Gauthier, Y., and Drouin, J. (2005). Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness. J. Biol. Chem. 280, 19746-19756.
5. Bignell, G. R., Barfoot, R., Seal, S., Collins, N., Warren, W., and Stratton, M. R. (1998). Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer. Cancer Res. 58, 1384-1386. (Pubitemid 28193595)
6. Bocquel, M. T., Kumar, V., Stricker, C., Chambon, P., and Gronemeyer, H. (1989). The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucleic Acids Res. 17, 2581-2595. (Pubitemid 19103239)
7. Boudeau, J., Kieloch, A., Alessi, D. R., Stella, A., Guanti, G., and Resta, N. (2003). Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers syndrome patients. Hum. Mutat. 21, 172.
8. Carretero, J., Medina, P. P., Pio, R., Montuenga, L. M., and Sanchez-Cespedes, M. (2004). Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene. Oncogene 23, 4037-4040. (Pubitemid 38747933)
9. Castro-Rivera, E, Samudio, I., and Safe, S. (2001). Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J. Biol. Chem. 276, 30853-30861.
10. Chen, D., Huang, S.-M., and Stallcup, M. R. (2000). Synergistic, p160 coactivator- dependent enhancement of estrogen receptor function by CARM1 and p300. J. Biol. Chem. 275, 40810-40816.
11. DiRenzo, J., Shang, Y., Phelan, M., Sif, S., Myers, M., Kingston, R., and Brown, M. (2000). BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol. Cell Biol. 20, 7541-7549.
12. Dorfman, J., and Macara, I. G. (2008). STRAD{alpha} Regulates LKB1 Localization by Blocking Access to Importin-{alpha}, and by Association with Crm1 and Exportin-7. Mol. Biol. Cell 19, 1614-1626.
13. Dubik, D., and Shiu, R. P. (1988). Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J. Biol. Chem. 263, 12705-12708.
14. Dutertre, M., and Smith, C. L. (2003). Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-{alpha}: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol. Endocrinol. 17, 1296-1314.
15. Esteller, M., Avizienyte, E., Corn, P. G., Lothe, R. A., Baylin, S. B., Aaltonen, L. A., and Herman, J. G. (2000). Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 19, 164-168. (Pubitemid 30066364)
16. Fan, S., Wang, J. A., Yuan, R., Ma, Y., Meng, Q., Erdos, M. R., Pestell, R. G., Yuan, F., Auborn, K. J., Goldberg, I. D., and Rosen, E. M. (1999). BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284, 1354-1356. (Pubitemid 29289660)
17. Fenton, H., Carlile, B., Montgomery, E., Carraway, H., Herman, J., Sahin, F., Su, G., and Argani, P. (2006). LKB1 protein expression in human breast cancer. Appl. Immunohistochem. Mol. Morphol. 14, 146-153.
18. Frigo, D. E., et al. (2006). p38 Mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Mol. Endocrinol. 20, 971-983.
19. Fritah, A., Saucier, C., Mester, J., Redeuilh, G., and Sabbah, M. (2005). p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor {alpha}. Mol. Cell Biol. 25, 2419-2430. (Pubitemid 40354635)
20. Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz-Correa, M., and Offerhaus, J. A. (2000). Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119, 1447-1453. (Pubitemid 32198669)
21. Hanstein, B., Eckner, R., DiRenzo, J., Halachmi, S., Liu, H., Searcy, B., Kurokawa, R., and Brown, M. (1996). p300 is a component of an estrogen receptor coactivator*complex. Proc. Natl. Acad. Sci. USA 93, 11540-11545.
22. Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Makela, T. P., Alessi, D. R., and Hardie, D. G. (2003). Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2, 28. (Pubitemid 37464489)
23. Hemminki, A. (1999). The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol. Life Sci. 55, 735-750.
24. Hemminki, A., et al. (1997). Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat. Genet. 15, 87-90.
25. Henry, K. W., Yuan, X., Koszewski, N. J., Onda, H., Kwiatkowski, D. J., and Noonan, D. J. (1998). Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J. Biol. Chem. 273, 20535-20539.
26. Hruban, R. H., Petersen, G. M., Goggins, M., Tersmette, A. C., Offerhaus, G. J., Falatko, F., Yeo, C. J., and Kern, S. E. (1999). Familial pancreatic cancer. Ann. Oncol. 10 (suppl 4), 69-73.
27. Ikeda, K., and Inoue, S. (2004). Estrogen receptors and their downstream targets in cancer. Arch. Histol. Cytol. 67, 435-442.
28. Kuiper, G. G., Enmark, E., Pelto-Huikkom M., Nilssonm S., and Gustafsson, J. A. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93, 5925-5930.
29. Kushner, P. J., Agard, D. A., Greene, G. L., Scanlan, T. S., Shiau, A. K., Uht, R. M., and Webb, P. (2000). Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74, 311-317.
30. Lee, J. E., Kim, K., Sacchettini, J. C., Smith, C. V., and Safe, S. (2005). DRIP150 Coactivation of estrogen receptor {alpha} in ZR-75 breast cancer cells is independent of LXXLL motifs. J. Biol. Chem. 280, 8819-8830.
31. Lim, W., et al. (2003). Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. Br. J. Cancer 89, 308-313.
32. Lizcano, J. M., et al. (2004). LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23, 833-843.
33. Lu, J., and Danielsen, M. (1998). Differential regulation of androgen and glucocorticoid receptors by retinoblastoma protein. J. Biol. Chem. 273, 31528-31533.
34. Marignani, P. A. (2005). LKB1, the multitasking tumour suppressor kinase. J. Clin. Pathol. 58, 15-19.
35. Marignani, P. A., and Carpenter, C. L. (2001). Vav2 is required for cell spreading. J. Cell Biol. 154, 177-186. (Pubitemid 34289287)
36. Marignani, P. A., Kanai, F., and Carpenter, C. L. (2001). LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J. Biol. Chem. 276, 32415-32418.
37. Marignani, P. A., Scott, K. D., Bagnulo, R., Cannone, D., Ferrari, E., Stella, A., Guanti, G., Simone, C., and Resta, N. (2007). Novel splice isoforms of STRAD-alpha differentially affect LKB1 activity, complex assembly and subcellular localization. Cancer Biol. Ther. 6, 1627-1631.
38. Métivier, R., Penot, G., Hübner, M., Reid, G., Brand, H., Kos, M., and Gannon, F. (2003). Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115, 751-763. (Pubitemid 38030303)
39. Moilanen, A.-M., Karvonen, U., Poukka, H., Janne, O. A., and Palvimo, J. J. (1998). Activation of androgen receptor function by a novel nuclear protein kinase. Mol. Biol. Cell 9, 2527-2543.
40. Nakanishi, C., Yamaguchi, T., Iijima, T., Saji, S., Toi, M., Mori, T., and Miyaki, M. (2004). Germline mutation of the LKB1/STK11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome. Oncology 67, 476-479.
41. Nezu, J., Oku, A., and Shimane, M. (1999). Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients. Biochem. Biophys. Res. Commun. 261, 750-755.
42. Nilsson, S., Makela, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., and Gustafsson, J. A. (2001). Mechanisms of estrogen action. Physiol. Rev. 81, 1535-1565.
43. O'Lone, R., Frith, M. C., Karlsson, E. K., and Hansen, U. (2004). Genomic targets of nuclear estrogen receptors. Mol. Endocrinol. 18, 1859-1875.
44. Partanen, J. I., Nieminen, A. I., Makela, T. P., and Klefstrom, J. (2007). Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. Proc. Natl. Acad. Sci. USA 104, 14694-14699.
45. Sabbah, M., Courilleau, D., Mester, J., and Redeuilh, G. (1999). Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc. Natl. Acad. Sci. USA 96, 11217-11222.
46. Sakamoto, K., Goransson, O., Hardie, D. G., and Alessi, D. R. (2004). Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR. Am. J. Physiol. Endocrinol. Metab. 287, E310-E317.
47. Sanchez-Cespedes, M., Parrella, P., Esteller, M., Nomoto, S., Trink, B., Engles, J. M., Westra, W. H., Herman, J. G., and Sidransky, D. (2002). Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 62, 3659-3662. (Pubitemid 34728843)
48. Scott, K. D., Nath-Sain, S., Agnew, M. D., and Marignani, P. A. (2007). LKB1 Catalytically Deficient Mutants Enhance Cyclin D1 Expression. Cancer Res. 67, 5622-5627. (Pubitemid 46984992)
49. Shang, Y., and Brown, M. (2002). Molecular determinants for the tissue specificity of SERMs. Science 295, 2465-2468. (Pubitemid 34270263)
50. Shen, Z., Wen, X. F., Lan, F., Shen, Z. Z., and Shao, Z. M. (2002). The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin. Cancer Res. 8, 2085-2090.
51. Shoker, B. S., Jarvis, C., Davies, M.P.A., Iqbal, M., Sibson, D. R., and Sloane, J. P. (2001). Immunodetectable cyclin D1is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. Br. J. Cancer 84, 1064-1069. (Pubitemid 32448503)
52. Singh, P., Coe, J., and Hong, W. (1995). A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 374, 562-565.
53. Smith, C., Oñate, S., Tsai, M., and O'Malley, B. (1996). CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. USA 93, 8884-8888.
54. Sommer, S., and Fuqua, S. A. (2001). Estrogen receptor and breast cancer. Semin. Cancer Biol. 11, 339-352.
55. Szapary, D., Huang, Y., and Simons, S. S., Jr. (1999). Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Mol. Endocrinol. 13, 2108-2121.
56. Tiainen, M., Vaahtomeri, K., Ylikorkala, A., and Makela, T. P. (2002). Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1). Hum. Mol. Genet. 11, 1497-1504.
57. Tiainen, M., Ylikorkala, A., and Makela, T. P. (1999). Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. Proc. Natl. Acad. Sci. USA 96, 9248-9251.
58. Trotter, K., and Archer, T. K. (2008). The BRG1 transcriptional coregulator. Nucl. Recept. Signal 6, 1-12.
59. Walter, P., Green, S., Greene, G., Krust, A., Bornert, J. M., Jeltsch, J. M., Staub, A., Jensen, E., Scrace, G., and Waterfield, M. (1985). Cloning of the human estrogen receptor cDNA. Proc. Natl. Acad. Sci. USA 82, 7889-7893.
60. Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E. V. (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369, 669-671. (Pubitemid 24199473)
61. Wang, Z. J., Ellis, I., Zauber, P., Iwama, T., Marchese, C., Talbot, I., Xue, W. H., Yan, Z. Y., and Tomlinson, I. (1999). Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers' syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence. J. Pathol. 188, 9-13. (Pubitemid 29197307)
62. Webb, P., Lopez, G. N., Greene, G. L., Baxter, J. D., and Kushner, P. J. (1992). The limits of the cellular capacity to mediate an estrogen response. Mol. Endocrinol. 6, 157-167.
63. Weigel, N., and Moore, N. L. (2007). Kinases and protein phosphorylation as regulators of steroid hormone action. Nucl. Recept. Signal. 5, e005.
64. Yang, T. L., Su, Y. R., Huang, C. S., Yu, J. C., Lo, Y. L., Wu, P. E., and Shen, C. Y. (2004). High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity. Genes Chromosomes Cancer 41, 250-256. (Pubitemid 39299295)
65. Yeh, S., Miyamoto, H., Nishimura, K., Kang, H., Ludlow, J., Hsiao, P., Wang, C., Su, C., and Chang, C. (1998). Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. Biochem. Biophys. Res. Commun. 248, 361-367.
66. Ylikorkala, A., et al. (1999). Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum. Mol. Genet. 8, 45-51.
67. Yu, C.-L., Driggers, P., Barrera-Hernandez, G., Nunez, S. B., Segars, J. H., and Cheng, S.-Y. (1997). The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways. Biochem. Biophys. Res. Commun. 239, 617-620.